• About Us
    • Overview
    • Education
    • Mission & History
    • Board of Directors
    • The Campus
    • Careers
  • Our Achievements
    • Overview
    • Cancer
    • Technology
    • Education
    • Our Planet
    • Health & Medicine
    • Physical World
  • Get Involved
    • Overview
    • Partners in Science
    • Estate & Planned Giving
    • Attend an Event
    • Gift Opportunities
  • News & Media
    • Overview
    • News & Media Archive
    • Coronavirus
    • Feature Stories
    • News Releases
    • In The News
    • Video Gallery
    • Ad Campaigns
    • Celebrating Great Minds
  • Blog
  • Contact
  • Donate
Donate
Donate
About Us tri
About Us Overview
  • Education
  • Mission & History
  • Board of Directors
  • The Campus
  • Careers
About Us

Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.

Our Achievements tri
Our Achievements Overview
  • Cancer
  • Technology
  • Education
  • Our Planet
  • Health & Medicine
  • Physical World
Our Achievements

The Weizmann Institute’s fundamental research has led to discoveries and applications with a major impact on the scientific community and on the quality of life for millions worldwide.

Get Involved tri
Get Involved Overview
  • Partners in Science
  • Estate & Planned Giving
  • Attend an Event
  • Gift Opportunities
Get Involved

Join a community of dedicated people who share the Weizmann Institute’s commitment to shaping a better world through science.

News & Media tri
News & Media Overview
  • News & Media Archive
  • Coronavirus
  • Feature Stories
  • News Releases
  • In The News
  • Video Gallery
  • Ad Campaigns
  • Celebrating Great Minds
News & Media

Learn about the Weizmann Institute’s latest groundbreaking discoveries and the American Committee’s activities across the country.

Blog tri
  • The Curiosity Review
Blog

Popular science for the curious-minded: The Curiosity Review brings discovery to life.

Contact

Search Results

  • SEARCH BY KEYWORD
  • SEARCH BY TAG
View Articles by Tag:
  • View Articles by Tag
  • Algorithims (6)
  • Alternative energy (27)
  • Alzheimers (44)
  • Archaeology (37)
  • Artificial intelligence (20)
  • Astrophysics (108)
  • Autism (22)
  • Awards (119)
  • Bacteria (107)
  • Behavior (9)
  • Biochemistry (101)
  • Biofuel (7)
  • Biology (309)
  • Biomolecular sciences (7)
  • Blood (43)
  • Brain (175)
  • Cancer (163)
  • Cancer treatment (127)
  • Central nervous system (9)
  • Chemistry (78)
  • Children (7)
  • Circadian clock (1)
  • Climate change (73)
  • Clinical trials (40)
  • Collaborations (19)
  • Community (279)
  • Computers (73)
  • Copaxone (12)
  • Coronavirus (7)
  • Culture (359)
  • Diabetes (32)
  • Earth (74)
  • Education (157)
  • Environment (92)
  • Enzymes (29)
  • Evolution (89)
  • Fertility (20)
  • Fungus (4)
  • Genetics (109)
  • Genomics (3)
  • Heart (5)
  • Heart disease (3)
  • Humanity (83)
  • Immune system (149)
  • Immunology (10)
  • Immunotherapy (34)
  • Inflammation (19)
  • Leadership (114)
  • Leukemia (12)
  • Materials (44)
  • Mathematics (62)
  • Medicine (84)
  • Memory (39)
  • Mental health (58)
  • Metabolism (51)
  • Microbiology (2)
  • Microbiome (10)
  • Molecular cell biology (9)
  • Molecular genetics (61)
  • Multiple sclerosis (12)
  • Nanoscience (33)
  • Nature (4)
  • Neurobiology (2)
  • Neuroscience (207)
  • Nutrition (72)
  • Optics (34)
  • Organs (11)
  • Parkinsons (11)
  • Personalized medicine (5)
  • Philanthropy (148)
  • Physics (139)
  • Plants (56)
  • Proteins (96)
  • Quantum computer (3)
  • Quantum physics (2)
  • Quantum theory (34)
  • Robots (8)
  • Security (21)
  • Senses (115)
  • Sensors (8)
  • Smoking (1)
  • Solar power (19)
  • Space (110)
  • Stem cells (49)
  • Technology (206)
  • Vaccine (40)
  • Virus (135)
  • Water (40)
  • Weather (1)
  • Women (115)
  • World hunger (17)
Filter by Time:
  • All
  • Past Day
  • Past Week
  • Past Month
  • Past Year
  • Past Three Years
Clear Filters

127 results for Cancer treatment

Gilead Buys Kite Pharma, Founded by Israelis, for $11.9 Billion
Gilead Buys Kite Pharma, Founded by Israelis, for $11.9 Billion

https://weizmann-usa.org/news-media/in-the-news/gilead-buys-kite-pharma-founded-by-israelis-for-11-9-billion/

Aug 29, 2017... The headquarters of Gilead Sciences in Foster City, California Credit: Eric Risberg, AP
The almost $12 billion that Gilead Sciences agreed on Monday to pay for Kite Pharma is testament not only to Israeli innovation but also to the entrepreneurship of Kite’s Israeli founder and CEO, Prof. Arie Belldegrun, and his ability to leverage a vast store of medical knowledge and Wall Street connections.

TAGS: Cancer, Cancer treatment, Immunotherapy

Target: Blood Cancers
Target: Blood Cancers

https://weizmann-usa.org/news-media/feature-stories/target-blood-cancers/

Feb 06, 2017... Our blood is our very life force, performing the basic functions that keep us alive. It carries nutrients and oxygen to our cells, and bears away metabolic waste. And yet it also plays a role in a number of all-too-common diseases, such as blood cancers. In fact, according to the Leukemia & Lymphoma Society, someone is diagnosed with a blood cancer every three minutes.
Blood cancers begin in the bone marrow, where blood cells are produced, or in the lymphatic system, which removes excess fluids from the body’s tissues and produces immune cells. In most blood cancers, uncontrolled growth of abnormal blood cells interferes with the development and function of normal, healthy blood cells.

TAGS: Women, Cancer, Cancer treatment, Blood

Profiling a Killer in Warm Blood
Profiling a Killer in Warm Blood

https://weizmann-usa.org/news-media/news-releases/profiling-a-killer-in-warm-blood/

Dec 06, 2018... Tumor heterogeneity, clonal evolution, and therapy resistance are revealed using single-cell profiling of multiple myeloma patients
REHOVOT, ISRAEL —December 6, 2018—Cancer arises when cells lose control. Deciphering the “blueprint” of cancer cells – outlining how cancer cells hijack specific pathways for uncontrolled proliferation – will lead to more efficient ways to fight it. Now, in a joint effort, scientists from the Weizmann Institute of Science and clinicians from major hemato-oncology departments in Israel have successfully created detailed profiles of myeloma cancer in both pre-cancer stages, in newly diagnosed multiple myeloma patients, as well as post-treatment and relapse. These detailed blueprints will help in future precision diagnosis and treatment of this disease.

TAGS: Technology, Cancer, Cancer treatment, Immune system, Blood

Science Tips, October 2015
Science Tips, October 2015

https://weizmann-usa.org/news-media/news-releases/science-tips-october-2015/

Oct 26, 2015... Of the hundreds of genes that can be mutated in a single case of melanoma, only a handful may be true “drivers” of cancer. In research that recently appeared in Nature Genetics, a Weizmann Institute of Science team has now revealed one of the drivers of a particularly deadly subset of melanomas that is seeing a rise in new cases. This gene is a newly identified member of a group of genes called tumor suppressor genes, and is mutated in some 5.4% of melanomas. Furthermore, its expression was found to be lost in over 30% of human melanomas; this loss, according to the research, was associated with reduced patient survival. The discovery might open new doors to understanding how this cancer grows and spreads, and may lead in the future to new directions in treatment.

TAGS: Plants, Cancer, Cancer treatment, Immune system, Proteins

Why Chemotherapy Fails
Why Chemotherapy Fails

https://weizmann-usa.org/news-media/news-releases/why-chemotherapy-fails/

May 29, 2012... REHOVOT, ISRAEL—May 29, 2012—The fight against cancer is not won in a single battle: long after a cancer has been beaten into remission, it can return. The reason for this is under debate, and much is unclear. New research led by Weizmann Institute scientists shows that, at least for one type of blood cancer, the source of cancer recurrence is in a set of cells that do not proliferate as quickly as regular cancer cells, and thus are able to survive chemotherapy. The findings, which appear in the journal Blood, have some important implications for the future of the war on cancer.

TAGS: Cancer, Cancer treatment, Stem cells, Blood

Safer Chemo, Thanks to Israeli Math
Safer Chemo, Thanks to Israeli Math

https://weizmann-usa.org/news-media/in-the-news/safer-chemo-thanks-to-israeli-math/

Oct 10, 2012... Not all white blood cells are created equal. Image via www.shutterstock.com
Waning white blood-cell counts in chemotherapy patients are commonly taken as a warning of an increased risk of infection.
Now, a new Israeli study suggests that it is critical to evaluate not only the quantity of these “neutrophil” blood cells essential to immunity against infection, but also their quality, which varies from one patient to another.

TAGS: Medicine, Cancer, Cancer treatment, Bacteria, Mathematics

Understanding Immunotherapy: History and Lifesaving Breakthroughs
Understanding Immunotherapy: History and Lifesaving Breakthroughs

https://weizmann-usa.org/news-media/video-gallery/understanding-immunotherapy-history-and-lifesaving-breakthroughs/

Nov 01, 2016... Understanding Immunotherapy: History and Lifesaving Breakthroughs

TAGS: Cancer, Cancer treatment, Immune system, Immunotherapy, Multiple sclerosis, Leukemia, Copaxone

Working Toward Personalized Cancer Treatment
Working Toward Personalized Cancer Treatment

https://weizmann-usa.org/news-media/feature-stories/working-toward-personalized-cancer-treatment/

Jul 10, 2018... Prof. Yardena Samuels wants to reveal the big cancer picture.
“We don’t just want to find the genes involved in cancer,” says Prof. Yardena Samuels of the Weizmann Institute of Science’s Department of Molecular Cell Biology, “we want to understand what those genes do. We want to reveal the complete picture of a cancer genome.”
That is something of a tall order, considering that cells from melanoma, the cancer Prof. Samuels is researching, can contain anywhere from tens to thousands of mutations. On average, melanoma – the deadliest form of skin cancer – has more mutations in the DNA of its cells than any other solid tumor. Among other things, this range of mutations explains why a recent treatment designed to target melanoma will only help around 50% of those with the disease, despite representing a large step forward.

TAGS: Women, Cancer, Cancer treatment

Weizmann in Focus, Episode 4: Conquering Blood Cancer
Weizmann in Focus, Episode 4: Conquering Blood Cancer

https://weizmann-usa.org/news-media/video-gallery/weizmann-in-focus-episode-4-conquering-blood-cancer/

Apr 16, 2019... The Weizmann Institute brings together scientists from a variety of disciplines to tackle cancer head-on. In the fourth episode of Weizmann in Focus, CEO Dave Doneson highlights a recent headline-making breakthrough from the labs of Profs. Ido Amit and Amos Tanay. Working with hospitals across Israel, the scientists identified a very small number of malignant cells in what is considered a pre-malignant stage of multiple myeloma—the second-most common type of blood cancer. Their discovery holds the promise of earlier, more precise treatment.

TAGS: Technology, Community, Cancer, Cancer treatment, Philanthropy, Leadership, Blood

Saving Your Skin: Melanoma Awareness
Saving Your Skin: Melanoma Awareness

https://weizmann-usa.org/news-media/feature-stories/saving-your-skin-melanoma-awareness/

May 10, 2016... May is Melanoma/Skin Cancer Detection and Prevention Month: the perfect time to learn more about the disease – and what the Weizmann Institute of Science is doing to help.
Skin cancer is the most common cancer in America, and it’s on the rise, at least in part due to the increased intensity of ultraviolet (UV) rays as a result of climate change. In fact, while skin cancers can have several causes, “the vast majority of melanomas are caused by the sun,” according to the Skin Cancer Foundation, which also cites a U.K. study finding that “about 86 percent of melanomas can be attributed to exposure to ultraviolet … radiation from the sun.”

TAGS: Cancer, Cancer treatment

First … 1 2 3 4 5 6 7 8 9 10 11 ... Last
Back Next
SHARE

Our Achievements

Learn more about remarkable Weizmann Institute achievements that are enhancing and transforming our lives.

Learn More

Support Our Flagship Projects

Help us accelerate exciting initiatives in three forward-looking fields: neuroscience, physics, and artificial intelligence.

Learn More

Newsletter

Get the latest news and breakthroughs from the Weizmann Institute of Science.

About Us
  • Education
  • Mission & History
  • Board of Directors
  • The Campus
  • Careers
Our Achievements
  • Cancer
  • Technology
  • Education
  • Our Planet
  • Health & Medicine
  • Physical World
Get Involved
  • Partners in Science
  • Estate & Planned Giving
  • Attend an Event
  • Gift Opportunities
News & Media Blog: Curiosity Review Donate Now Contact Us
Privacy Policy Gift Acceptance Policy Financial Information

©2023 American Committee for the Weizmann Institute of Science

Charity Navigator

FOR THE FOURTH CONSECUTIVE YEAR

Platinum Transparency 2023